RF
Regina Fritsche-Danielson
SVP and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) at AstraZeneca
About
Regina Fritsche-Danielson serves as the Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism at AstraZeneca.
Position in the VCSift Database
- • 7 investors at AstraZeneca are tracked.
- • 1 investors hold the SVP and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) role in VCSift. Regina Fritsche-Danielson is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
linkedin.com/in/••••••••
Find more investors like Regina
Search Investors